Options
Microbial degradation of fluorinated drugs: biochemical pathways, impacts on the environment and potential applications
Author(s)
Date Issued
2016-03
Date Available
2017-07-10T15:15:18Z
Abstract
Since the discovery over 60 years ago of fluorocortisone's biological properties (9-α-Fluoro derivatives of cortisone and hydrocortisone; Fried J and Sabo EF, J Am Chem Soc 76: 1455–1456, 1954), the number of fluorinated drugs has steadily increased. With the improvement in synthetic methodologies, this trend is likely to continue and will lead to the introduction of new fluorinated substituents into pharmaceutical compounds. Although the biotransformation of organofluorine compounds by microorganisms has been well studied, specific investigations on fluorinated drugs are relatively few, despite the increase in the number and variety of fluorinated drugs that are available. The strength of the carbon-fluorine bond conveys stability to fluorinated drugs; thus, they are likely to be recalcitrant in the environment or may be partially metabolized to a more toxic metabolite. This review examines the research done on microbial biotransformation and biodegradation of fluorinated drugs and highlights the importance of understanding how microorganisms interact with this class of compound from environmental, clinical and biotechnological perspectives.
Type of Material
Journal Article
Publisher
Springer
Journal
Applied Microbiology and Biotechnology
Volume
100
Issue
6
Start Page
2617
End Page
2627
Copyright (Published Version)
2016 Springer
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
File(s)
Owning collection
Scopus© citations
49
Acquisition Date
Mar 28, 2024
Mar 28, 2024
Views
1296
Acquisition Date
Mar 28, 2024
Mar 28, 2024
Downloads
440
Last Month
9
9
Acquisition Date
Mar 28, 2024
Mar 28, 2024